Alcon AG (ALC)vsSTAAR Surgical Company (STAA)
ALC
Alcon AG
$75.26
+1.37%
HEALTHCARE · Cap: $37.11B
STAA
STAAR Surgical Company
$19.19
+1.16%
HEALTHCARE · Cap: $867.46M
Smart Verdict
WallStSmart Research — data-driven comparison
Alcon AG generates 4244% more annual revenue ($10.40B vs $239.44M). ALC leads profitability with a 9.4% profit margin vs -33.6%. STAA appears more attractively valued with a PEG of 0.76. ALC earns a higher WallStSmart Score of 49/100 (D+).
ALC
Hold49
out of 100
Grade: D+
STAA
Hold42
out of 100
Grade: D
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
-489.8%
Fair Value
$13.46
Current Price
$75.26
$61.80 premium
Intrinsic value data unavailable for STAA.
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Conservative balance sheet, low leverage
Reasonable price relative to book value
Conservative balance sheet, low leverage
Growing faster than its price suggests
Reasonable price relative to book value
18.1% revenue growth
Areas to Watch
Expensive relative to growth rate
Premium valuation, high expectations priced in
ROE of 4.5% — below average capital efficiency
Earnings declined 22.2%
Smaller company, higher risk/reward
Weak financial health signals
ROE of -21.7% — below average capital efficiency
Earnings declined 10.5%
Comparative Analysis Report
WallStSmart ResearchBull Case : ALC
The strongest argument for ALC centers on Debt/Equity, Price/Book.
Bull Case : STAA
The strongest argument for STAA centers on Debt/Equity, PEG Ratio, Price/Book. Revenue growth of 18.1% demonstrates continued momentum. PEG of 0.76 suggests the stock is reasonably priced for its growth.
Bear Case : ALC
The primary concerns for ALC are PEG Ratio, P/E Ratio, Return on Equity.
Bear Case : STAA
The primary concerns for STAA are Market Cap, Piotroski F-Score, Return on Equity.
Key Dynamics to Monitor
ALC profiles as a value stock while STAA is a growth play — different risk/reward profiles.
STAA carries more volatility with a beta of 1.05 — expect wider price swings.
STAA is growing revenue faster at 18.1% — sustainability is the question.
ALC generates stronger free cash flow (489M), providing more financial flexibility.
Bottom Line
ALC scores higher overall (49/100 vs 42/100). Both earn "Hold" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Alcon AG
HEALTHCARE · MEDICAL INSTRUMENTS & SUPPLIES · USA
Alcon, Inc., an eye care company, researches, develops, manufactures, distributes and sells eye care products for eye care professionals and their patients around the world. The company is headquartered in Geneva, Switzerland.
Visit Website →STAAR Surgical Company
HEALTHCARE · MEDICAL INSTRUMENTS & SUPPLIES · USA
STAAR Surgical Company designs, develops, manufactures, markets and sells implantable eye lenses and supplemental delivery systems for placing the lenses in the eye. The company is headquartered in Lake Forest, California.
Visit Website →Compare with Other MEDICAL INSTRUMENTS & SUPPLIES Stocks
Want to dig deeper into these stocks?